It is a great pleasure to serve under your chairmanship, Dame Maria. I begin by congratulating my hon. Friend the Member for Stoke-on-Trent South on securing this important debate and his colleagues who supported him with enthusiasm, passion, conviction and ability. My hon. Friend has made an extremely moving and compelling case for the terrible effects that monkey dust has on constituents—not just those who are taking it but those affected by their behaviour. Monkey dust is a street name for drugs in the family of cathinones, which act as central-nervous-system stimulants similar to amphetamines. The Government's 10-year drug strategy focuses on preventing misuse through the criminal justice system and policing, including recruiting 20,000 extra police officers with over 15,000 already recruited. Police funding will be reviewed in the near future, with £780 million allocated for treatment and recovery to cure addiction. Stoke-on-Trent is part of the first wave of authorities receiving additional funding this year, approximately an additional £1 million specifically for treating addiction. Sir Stephen House's report on reducing bureaucracy for police time is being worked on closely. Regarding drug classification under the Misuse of Drugs Act 1971, the Government have a statutory obligation to consult the Advisory Council on the Misuse of Drugs before making any change. The ACMD advised in 2010 to maintain class B classification for cathinones, but recent developments indicate significant escalation since then. In response to this debate, I intend to commission Home Office officials to advise on whether we should submit the cathinone family of drugs to the ACMD for an updated evaluation to see whether reclassification is needed. This demonstrates the value of these debates in prompting action which otherwise would not have taken place.